太龙药业(600222.SH)前三季度净利润2532.55万元，同比下降12.36%

Core Viewpoint - Tai Long Pharmaceutical (600222.SH) reported a decline in revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The total operating revenue for the first three quarters reached 1.187 billion yuan, a year-on-year decrease of 11.47% [1] - The net profit attributable to shareholders was 25.3255 million yuan, down 12.36% year-on-year [1] - Basic earnings per share were reported at 0.0458 yuan [1] Dividend Announcement - The company plans to distribute a cash dividend of 0.14 yuan (including tax) for every 10 shares to all shareholders [1]